Who are DHA Omega-3's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/dha-omega-3.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

DHA Omega-3 — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

DHA Omega-3 (DHA Omega-3) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Omega-3 fatty acid / Nutritional supplement. Area: Cardiovascular / Neurology.

phase 3 Omega-3 fatty acid / Nutritional supplement Cardiovascular / Neurology Small molecule Live · refreshed every 30 min

Target snapshot

DHA Omega-3 (DHA Omega-3) — University of Cincinnati. DHA (docosahexaenoic acid) omega-3 fatty acid reduces inflammation and supports cardiovascular and neurological health through modulation of lipid metabolism and inflammatory pathways.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
DHA Omega-3 TARGET	DHA Omega-3	University of Cincinnati	phase 3	Omega-3 fatty acid / Nutritional supplement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Omega-3 fatty acid / Nutritional supplement class)

University of Cincinnati · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). DHA Omega-3 — Competitive Intelligence Brief. https://druglandscape.com/ci/dha-omega-3. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing